Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats

Bone: Incretin Hormones Perceiver or Receiver?

(2012) Ilaria Dicembrini et al.   Experimental Diabetes Research

Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives

(2012) Roland Baron et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New factors controlling the balance between osteoblastogenesis and adipogenesis

(2011) Basem M. Abdallah et al.   BONE

Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes

(2011) Borzo Gharibi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia

(2011) Bernardo Nuche-Berenguer et al.   JOURNAL OF ENDOCRINOLOGY

Management of type 2 diabetes: new and future developments in treatment

(2011) Abd A Tahrani et al.   LANCET

Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

(2010) E. S. Horton et al.   DIABETES CARE

Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation

(2010) Lotte Bjerre Knudsen et al.   ENDOCRINOLOGY

Bone Marrow Fat Is Inversely Related to Cortical Bone in Young and Old Subjects

(2010) Tishya A. L. Wren et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

(2009) C. Sanz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Four-month treatment with GLP-2 significantly increases hip BMD

(2009) Dennis B. Henriksen et al.   BONE

Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States

(2009) Bernardo Nuche-Berenguer et al.   CALCIFIED TISSUE INTERNATIONAL

Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation

(2009) X. Ma et al.   DIABETES OBESITY & METABOLISM

Thrombospondin-2 Influences the Proportion of Cartilage and Bone During Fracture Healing

(2009) Douglas K Taylor et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Obesity and fractures in postmenopausal women

(2009) Melissa Orlandin Premaor et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states

(2009) Bernardo Nuche-Berenguer et al.   REGULATORY PEPTIDES

Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation

(2008) Martina Rauner et al.   AGE

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption

(2007) Chizumi Yamada et al.   ENDOCRINOLOGY